MINA THERAPEUTICS LIMITED

Active London

Research and experimental development on biotechnology

28 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MINA THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 7 Mar 2008 Active London, United Kingdom 28 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 25 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 16 Apr 2026 Next due 21 Mar 2027 10 months remaining
Net assets £-52M £6M 2024 year on year
Total assets £5M £4M 2024 year on year
Total Liabilities £58M £2M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Translation & Innovation Hub 84 Wood Lane London W12 0BZ United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for MINA THERAPEUTICS LIMITED (06527890), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 7 Mar 2008. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

£761.55k

Decreased by £2.97M (-80%)

Net Assets

-£52.48M

Decreased by £5.63M (-12%)

Total Liabilities

£57.66M

Increased by £1.72M (+3%)

Turnover

N/A

Employees

28

Decreased by 1 (-3%)

Debt Ratio

1113%

Increased by 497 (+81%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Galantine-heller, StephanieDirectorFrenchEngland4317 Feb 2025Active
Yael Gruenbaum-cohenDirectorIsraeliIsrael4917 Feb 2025Active

Shareholders

Shareholders (1)

Mina (holdings) Limited
0.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MINA THERAPEUTICS LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Apr 2026Confirmation StatementConfirmation statement made on 7 Mar 2026 with no updates
16 Apr 2026OfficersAppointment of Stephanie Galantine-Heller as director
5 Jan 2026OfficersChange to director Dr. Norbert Wolfgang Bischofberger on 5 Jan 2026
24 Dec 2025OfficersChange to director Mr Robert Kopple on 24 Dec 2025
24 Dec 2025OfficersChange to director Mr Robert Charles Kopple on 24 Dec 2025
16 Apr 2026 Confirmation Statement

Confirmation statement made on 7 Mar 2026 with no updates

16 Apr 2026 Officers

Appointment of Stephanie Galantine-Heller as director

5 Jan 2026 Officers

Change to director Dr. Norbert Wolfgang Bischofberger on 5 Jan 2026

24 Dec 2025 Officers

Change to director Mr Robert Kopple on 24 Dec 2025

24 Dec 2025 Officers

Change to director Mr Robert Charles Kopple on 24 Dec 2025

Recent Activity

Latest Activity

Confirmation statement made on 7 Mar 2026 with no updates

1 weeks ago on 16 Apr 2026

Appointment of Stephanie Galantine-Heller as director

1 weeks ago on 16 Apr 2026

Change to director Dr. Norbert Wolfgang Bischofberger on 5 Jan 2026

3 months ago on 5 Jan 2026

Change to director Mr Robert Kopple on 24 Dec 2025

4 months ago on 24 Dec 2025

Change to director Mr Robert Charles Kopple on 24 Dec 2025

4 months ago on 24 Dec 2025